glp-1 news november 2025 GLP-1 Drugs: 2025 Pulse Survey (U.S.) glp-1 news november 2025 ISPOR
Description
doi: 10.1056/NEJMoa1612917 81 RuffCTBaronMImKODonoghueMLFiedorekFTSabatineMS
Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease
In addition to GLP-1 medications, interventions like bariatric surgery fall under the medicinal pillar
-Rapid infusion
GLP-1 agonists, such as Ozempic, Mounjaro, Wegovy, and Zepbound, are a class of medications that have been rapidly rising in popularity
10.2147/DMSO.S528569 108 PintoL
